Method for treating prostate cancer

HK40138637APending Publication Date: 2026-10-09JIANGSU HENGRUI MEDICINE CO LTD +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: HK62026126303
Authority / Receiving Office: HK · HK
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2023-07-06
Filing Date: 2026-07-17
Publication Date: 2026-10-09
Estimated Expiration: 2044-07-04

Application Information

Patent Timeline

06 Jul 2023

Priority

17 Jul 2026

Application

HK62026126303

09 Oct 2026

Publication

HK40138637A

IPC: A61K31/496; A61P13/08; A61P35/00

Inventors: WANG, WENLIANG

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

Methods of treating prostate cancer. Specifically, the invention relates to an application of a compound shown as a formula I or a pharmaceutically acceptable salt thereof in preparation of a medicine for treating metastatic castration-resistant prostate cancer.

Need to check novelty before this filing date? Find Prior Art

Description

(19) State Intellectual Property Office (12) Invention Patent Application (10) Application Publication Number (43) Application Publication Date (21) Application Number 202480038139.7 (22) Application Date 2024.07.05 (66) Domestic Priority Data 202310825049.X 2023.07.06 CN (85) PCT International Application Entering National Phase Date 2025.12.08 (86) PCT International Application Application Data PCT / CN2024 / 103772 2024.07.05 (87) PCT International Application Publication Data WO2025 / 007946 ZH 2025.01.09 (71) Applicant Jiangsu Hengrui Medicine Co., Ltd. Address 222047 No. 7 Kunlunshan Road, Economic and Technological Development Zone, Lianyungang City, Jiangsu Province Applicant: Shanghai Shengdi Pharmaceutical Co., Ltd. (72) Inventor: Wang Wenliang (74) Patent Agency: Beijing Gecheng Intellectual Property Agency Co., Ltd. 11314 Patent Attorney: Cheng Wei (51) Int.Cl. A61K 31 / 496 (2006.01) A61P 13 / 08 (2006.01) A61P 35 / 00 (2006.01) (54) Invention Title: Method for Treating Prostate Cancer (57) Abstract: Method for treating prostate cancer. Specifically, the use of a compound of Formula I or a pharmaceutically acceptable salt thereof in the preparation of a medicament for treating metastatic castration-resistant prostate cancer. CN 121443295 A 2026.01.30 CN 1 21 44 32 95 A